Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL
Open Access
- 1 April 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Lipid Research
- Vol. 44 (4) , 800-806
- https://doi.org/10.1194/jlr.m200439-jlr200
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?Current Opinion in Lipidology, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease MortalityArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.Circulation, 1989
- Cholesterol and MortalityJAMA, 1987
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Multiple Risk Factor Intervention TrialJAMA, 1982